Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Hemangioma 3 Urinary Bladder Neoplasms 2 Sarcoma, Kaposi 2 Sarcoma 2 Multiple Myeloma 2 Melanoma 2 Hemangiosarcoma 2 Hemangioma, Cavernous, Central Nervous System 2 Breast Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Recurrence 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1 Digestive System Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 34 Etoposide 25 Doxorubicin 20 Carboplatin 20 Vincristine 19 Isotretinoin 19 Topotecan 17 Temozolomide 17 Irinotecan 16 Filgrastim 16 Melphalan 15 Cisplatin 15 sargramostim 14 Radiotherapy 14 Granulocyte-Macrophage Colony-Stimulating Factor 13 3-Iodobenzylguanidine 12 dinutuximab 11 Peripheral Blood Stem Cell Transplantation 11 naxitamab 9 Thiotepa 9 Magnetic Resonance Spectroscopy 9 humanized 3F8 anti-GD2 monoclonal antibody 7 Granulocyte Colony-Stimulating Factor 7 Busulfan 7 X-Rays 6 Specimen Handling 6 Phantoms, Imaging 6 Ifosfamide 6 Antilymphocyte Serum 6 fludarabine phosphate 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neuroblastoma × Propranolol × Clear all

NCT02641314 2024-05-10

METRO-NB2012

University of Cologne

Phase 2 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡